Panbela Therapeutics's market cap is currently ―. The company's EPS TTM is $-632.338; its P/E ratio is 0.00; Panbela Therapeutics is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $-1.62. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -6.43M	$ -5.91M	$ -5.03M	$ -4.57M	$ -4.37M
EBITDA	$ -6.19M	$ -5.91M	$ -5.03M	$ -4.57M	$ -4.37M
Net Income Common Stockholders	$ -6.49M	$ -5.83M	$ 4.61M	$ -4.74M	$ -4.40M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 2.58M	$ 7.21M	$ 5.24M	$ 1.28M	$ 941.00K
Total Assets	$ 11.80M	$ 19.55M	$ 16.48M	$ 4.98M	$ 4.87M
Total Debt	$ 5.19M	$ 5.19M	$ 5.19M	$ 6.84M	$ 6.84M
Net Debt	$ 2.62M	$ -2.01M	$ -41.00K	$ 5.56M	$ 5.90M
Total Liabilities	$ 16.51M	$ 14.75M	$ 13.94M	$ 13.03M	$ 13.15M
Stockholders Equity	$ -4.71M	$ 4.80M	$ 2.54M	$ -8.05M	$ -8.28M
Cash Flow	-
Free Cash Flow	$ -3.08M	$ -5.74M	$ -9.75M	$ -5.00M	$ -1.59M
Operating Cash Flow	$ -3.08M	$ -5.74M	$ -9.75M	$ -5.00M	$ -1.59M
Investing Cash Flow	-	-	-	-	$ -1.00K
Financing Cash Flow	$ 4.75M	$ 7.71M	$ 13.70M	$ 5.35M	$ 5.00K

Currency in USD

Panbela Therapeutics Earnings and Revenue History

Income Statement >

Panbela Therapeutics Debt to Assets

Balance Sheet >

Panbela Therapeutics Cash Flow

Cash Flow >

Panbela Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing